MSK Flashcards
compare inflammatory vs degenerative joint problems
inflammatory - pain eases with use - a lot of stiffness - >60minutes, early morning/at rest - swelling - synovial/bone - joints - hands and feet - pts young psoriasis, family history - responds to NSAIDS - hot and red degenerative - pain increases with use - clicks/clunks - stiffness not prolonged <30mins - morning/evening - swelling - none/bony - joints - CMCJ, DIPJ, knees - Pts - older, prior occupation/sport - doesn't respond to NSAIDS - not inflamed
describe two inflammatory markers that can be used to diagnose MSK disease
ESR - erythrocyte sedimentation rate
- raised in infection
- increased fibrinogen = RBC’s stick together = fall faster
- false positives : age, female, obesity, racial difference, hypercholesterolaemia, high Ig, anaemia
- rises and falls slowly
CRP - C reactive protein
- produced by liver in response to IL6 from activated macrophages
- rises and falls rapidly
- binds to damaged cells activating complement
- increases phagocytosis
list three types of autoimmune joint paint
- rheumatoid
- spondyloarthropathy (HLA B27 associated)
- connective tissue disorders
what are the features of spondyloarthropathy
- seronegativity - rheumatoid factor negative
- HLA B27 association - class I surface antigen on all cells, encoded by MHC on chromosome 6, human leucocyte antigen
- Axial arthritis - spine and SI joints
- asymmetrical large joint oligoarthritis
- enthesis - inflammation of site of insertion into tendon or ligament
- dactylitis - inflammation of entire digit
- extra articular - anterior uveitis, psoriasis, IBD, oral ulcers, aortic valve incompetence
describe the three theories to why HLA B27 is linked with disease
- molecular mimicking theory - infection —> immune response —-> infectious agent has peptides very similar to HLA B27 molecule —-> autoimmune response
- heavy chain homodimer hypothesis - heavy chains can form stable dimers and bind to NKreceptors + accumulate in ER, causing stress response
- misfolding theory - unfolded HLA B27 accumulate in ER causing pro inflammatory stress response and releasing IL23
describe ankylosing spondylitis
- a spondyloarthopathy
- inflammatory arthritis
- HLA B27 linked
- axial arthritis
- leads to new bone formation and fusion of the joints
- men present earlier < 30 years old
- syndesmophytes (new bone formation and vertical growth from anterior vertebral corners)
- sacroilitis - joint fusion
- eventually unable to look ahead whilst walking
- inflammation — erosive damage — repair —- new bone
- spectrum of disease
what are the signs of ankylosing spondylitis
- gradual onset of lower back pain
- worse during night with exercise relieving stiffness
- pain radiates from SI joints to buttocks/hips
- progressive loss of spinal movement
what are the tests for ankylosing spondylitis
- MRI -active inflammation
- X-rays - joint space decreased or increased, sclerosis, erosions, ankylosis/fusions. Vertebral syndesmophytes
- HLA B27 positive
what is the management of ankylosing spondylitis
- exercise
- NSAIDS
- TNFa blockers
- surgery
what are the 5 patterns of psoriatic arthritis
- symmetrical polyarthritis
- DIP joints
- axial
- large joint oligoarthritis
- arthritis mutilans (telescoping fingers)
what is the management of psoriatic arthritis
- NSAIDS
- anti TNFa drugs
- MTX, suldasalazine
what is reactive arthritis
- sterile inflammation of the synovial membrane, tendons and fascia triggered by an infection at a distant, usually GI or genital
GI - salmonella, shigella
STI - chylamidia, ureaplasma urealyticum
what are the signs of reactive arthitis
- arthritis
- conjunctivitis
- sterile urethritis
what are the tests for reactive arthritis
- ESR + CRP
- culture stool
- sexual health review
what is the pathology of RA
Inflammation - chronic inflammatory reaction - infiltation of lymphocytes, macrophages, plasma cells proliferation - tumour like mass - pannus - grows over articular cartilage - cartilage destruction by released proteinases e.g MMP - matrix mellatorproteinases - due to autoantibodies
what are the symptoms/signs of RA
- symmetrical swollen, painful and stiff small joints of hands and feet
- worse in morning
- general fatigue
- malaise
what are the extraarticular features of RA
- Heart disease
- pleural disease, small airways disease, diffuse fibrosing alveolitis
- eyes - sicca (dry eyes) , scleritis (corneal ulceration)
- skin
- nodules (lumps on skin)
- bursitis
- muscle wasting
- neuro - sensory peripheral neuropathy, entrapment neuropathy (swelling around nerves) e.g carpal tunnel
- instability of cervical spine (spinal cord compression/nerve root compression)
- pericarditis
- anaemia
- splenomegaly
- palpable lymph nodes
- amyloidosis
- analgesic nephropathy
- vasculitis
what are the tests for RA
- Anaemia
- increased ESR/CRP
- Positive rhuematoid factor in 80% - antibody against Fc portion of Ig - altered immune response
- anti CCP antibody - highly specific, relatively sensitive
what is the management of RA
- disease modifying anti rheumatic drugs (DMARD) e.g methotrexate
- steroids decrease symptoms and inflammation
- NSAIDS decrease symptoms e.g diclofenac
- physio
what is the pathology of vasculitis
- inflammation and necrosis of blood vessel walls with subsequent impaired
- vessel wall destruction - perforation and haemorrhage into tissues
- endothelial injury - thrombosis and ischaemia/infarction of dependent tissues
- infiltration of neutrophils, mononuclear cells and giant cells
-leukocytoclasis (dissolution of leucocytes)
-
give examples of large, medium and small vessel vasculitis
large - giant cell arteritis - takayasu's arteritis - isolated CNS angitis medium - classical polyarteritis nodosa (PAN) - Kawasaki disease small/med - wegeners granulomatosis - churg strauss - microscopic polyangitis small vessels - henoch schonlein purpura - essenial mixed cyyoglobulinaemia -cutaenous leucocytooclastic angitis
what are the symptoms of vasculitis
systemic - fever, malaise, weight loss, arthralgia/myalgia
skin - purpura, ulcers, livedo reticularis (pink blue mottling), digital gangrene
eyes - visual loss, scleritis, episcleritis
CV - angina/MI, HF, pericarditis
pulmonary - haemoptysis, dyspnoea
GI - pain or perforation
Renal - failure, inc BP, haematuria
Neuro - stroke, fits, confusion
what is ANCA and when is an ANCA result positive
antineutrophilic cytoplasmic antibodies
- positive in small/med vessel vasculitis
- specific antibodies for antigens in cytoplasmic granules of neutrophils and monocyte lysosomes
- detected with immunofluroscence microscopy
what is giant cell (temporal arteritis)
- granulomatous arteritis of aorta and large vessels - extracranial branches of carotid arteries
- > 50 yrs
- ANCA negative
- 2x more common in women
what are the diagnostic criteria or temporal/giant cell arteritis
3 or more:
- age > 50
- new headache
- temporal artery tenderness on decreased pulse
- ESR > 50mm/h
- abnormal artery biopsies showing necrotising artertis with mononuclear infiltrate or granulomatous inflammation
what are the symptoms of giant cell arteritis
- headache
- jaw claudation
- non specific malaise
- scalp tenderness
- acute blindness
- symptoms of polymyalgia rhuematica
what are the tests of temporal arteritis
- increased ESR, CRP
- increased platelet
- inc ALP
- decreased Hb
what is the management of temporal arteritis
- corticosteroids immediately
- falling ESR/CRP guides treatment
- prophylaxis of osteoporosis - bisphosphonate and vit D + DEXA
- steroid sparing agents - methotrexate
what is granulomatosis with polyangitis ( GPA)
- wegeners granulomatosis
- necrotizing granulomatous vasculitis of arterioles, capillaries and post capillary venules
- ANCA associated
- 25-60 years
- vasculature of all organ systems
what are the extravascular symptoms of GPA
- URT - sinusitis, otitis media
- lungs- pulmonary haemorrhage/nodules
- kidneys - glomerulonephritis
- skin - purpura/ulcers
- NS - CNS vasculitis
- pericarditis
- synovitis
- uveitis, scleritis
what is the management of GPA
- High dose steroids/ cyclophosphamide/ biologics (severe)
- moderate dose steroids + methotrexate (moderate)
what is osteoarthritis
- non inflammatory arthritis of movable joints characterised by deterioration of articular cartilage and the formation of new bone of the joint surfaces and margins
what are the predisposing factors of osteoarthritis
- genetic
- dominant trait with mendelian pattern
- hip, knee, dipj, pipj, cppd - trauma
- intraarticular
- long bone fractures with malalignment
- joint instability e.g torn ACL - deformities
- birth deformities, syndromes - occupation
- obesity
- bone density
- increased in patients with OA
What is the pathogenesis of osteoarthritis
- articular cartilage failure
- chondrocytes main cells responsible
- proteases - mellatoproteases
- catabolic cytokines -IL1, TNFa
- anabolic cytokines - insulin like GF, TGFb
- inflammation
what are the symptoms of osteoarthritis
- not systemic unlike inflammatory conditions pain (articular cartilage and synovium have no nerve supply, pain is from capsular stretching and vascular congestion of the bone) - insidious and increases over months or years - relieved by rest -aggrevated by activity - may be referred pain swelling - may be intermittent - effusion - continuous - capsular thickening stiffness - worse after periods of rest -muscle wasting - deformtiy - decreased ROM - crepitus - osteophytes palpable - heberdens nodes at DIP, bouchards at PIP - joint instability
what are the differential diagnoses of osteoarthritis
- rheumatoid
- gout
- osteonecrosis
- neuropathic joint
what are the investigations for osteoarthritis
xrays show - loss of joint space - osteophytes - subarticular sclerosis - subchondrial cysts CT -some joints not visible isotope bone scan - hot due to increased vascularity and new bone blood and synovial fluid all normal diagnostic injection to isolate joint affected arthroscopy CRP may be slightly elevated
what is the management of osteoarthritis
depends on
- joint
- stage of disorder
- severity of symptoms
- age
- functional needs
conservative/non surgical
- goals - decreased load on joint, relieve pain, promote movement
- lifestyle modification - diet and weight loss
- splints and orthotics - walking stick, soft soled shoes, heel raises
- exercise and physio to improve flexibility and strengthen muscle
- topical products - contain capsaicin, decrease pain by depleting stores of substance P. And NSAIDS
- Tablets - analgesics and glucosamine- constituents of proteoglycans which resists compression forces in the joint - paracetemol, NSAIDS and COX 2 inhibitors
injection
- steroid
- viscosupplementation agent - hyaluronic acid - cartilage matrix component
surgery
- goals: remove pain, improve function, correct deformity
- debridement of joint - removal of dead bone and waste products
- realignment of osteotomies - take bit of bone below joint (tibia) and add to top of articular surface to make joint space narrower
- joint excision
- joint fusion (arthrodesis) e.g ankle
- joint replacement (arthroplasty)
what is the pathology of systemic lupus erythematosus
- multisystemic autoimmune disease
- autoantibodies made against autoantigens such as ANA which form immune complexes
- inadequate clearance of immune complexes results in host of immune responses which cause tissue damage
- inflammation leading to scarring
- can be treated with immunosuppressive drugs
- thrombosis - phospholipid antibodies
which gene is systemic lupus erythematosus associated with
HLA DR2, DR3
what are the symptoms of signs of SLE
- acute cutaneous lupus: malar rash/butterfly
- chronic cutaneous lupus: discoid rash
- non scarring alopecia
- oral/nasal ulcers
- synvoitis
- serositis a) lung b) pericarditis
- urinalysis - proteinuria- glomerulonephritis
- neurological - seizures, psychosis, depression
- haemolytic anaemia
- leucopenia
- thrombocytopenia
- arthritis - symmetrical, less proliferative than RA, can be deforming, non erosive
what is the management of SLE
- Patient education and support
- UV protection
- assessment of lupus activity
- screening for major organ development
- topical - sunscreens, steroids, cytotoxic
- NSAIDS
- antimalarial
- anticoagulants
- biological - target B cells - rituximab, belimumab
- plasmapheresis
- stem cell transplant
what is raynauds phenomenon and what is it caused by
- peripheral digit ischaemia
- either primary or secondary to
- connective tissue disorders
systemic sclerosis, SLE, mixed connective - drugs
- vascular damage